Evidence map›Paper›PMID 24493748›Full record

ReviewPhilosophical transactions of the Royal Society of London. Series B, Biological sciences2014

Role of pHi, and proton transporters in oncogene-driven neoplastic transformation.

Stephan Joel Reshkin, Maria Raffaella Greco, Rosa Angela Cardone

Open access · bronzeAbstract readReview
In one paragraph

Review in Philosophical transactions of the Royal Society of London. Series B, Biological sciences, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 69 papers.

0numbers the graph read from it
0cells of the map it votes in
69citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

69 citing papers in PubMed, 129 citations in OpenAlex.

  1. Review
  2. Article
  3. Lactate, a Spearhead of Cancer Aggressiveness: Metabolic Reprogramming, Immune Suppression, and Metastatic Progression.Medical principles and practice : international journal of the Kuwait University, Health Science Centre · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Production and Role of Nitric Oxide in Endometrial Cancer.Antioxidants (Basel, Switzerland) · 2025
    Review
  9. Molecular biology of the cell · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Permissive role of NaMolecular and cellular biochemistry · 2022
    Article
  16. Review
  17. Review
  18. Role of pH Regulatory Proteins and Dysregulation of pH in Prostate Cancer.Reviews of physiology, biochemistry and pharmacology · 2022
    Article
  19. Review
  20. Article

9 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Stephan Joel ReshkinDepartment of Bioscience, Biotechnology and Biopharmaceutics, University of Bari, , Bari 70126, Italy.
Maria Raffaella Greco
Rosa Angela Cardone
Google (United States) · USUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The change of a normal, healthy cell to a transformed cell is the first step in the evolutionary arc of a cancer. While the role of oncogenes in this 'passage' is well known, the role of ion transporters in this critical step is less known and is fundamental to our understanding the early physiological processes of carcinogenesis. Cancer cells and tissues have an aberrant regulation of hydrogen ion dynamics leading to a reversal of the normal tissue intracellular to extracellular pH gradient (ΔpHi to ΔpHe). When this perturbation in pH dynamics occurs during carcinogenesis is less clear. Very early studies using the introduction of different oncogene proteins into cells observed a concordance between neoplastic transformation and a cytoplasmic alkalinization occurring concomitantly with a shift towards glycolysis in the presence of oxygen, i.e. 'Warburg metabolism'. These processes may instigate a vicious cycle that drives later progression towards fully developed cancer where the reversed pH gradient becomes ever more pronounced. This review presents our understanding of the role of pH and the NHE1 in driving transformation, in determining the first appearance of the cancer 'hallmark' characteristics and how the use of pharmacological approaches targeting pH/NHE1 may open up new avenues for efficient treatments even during the first steps of cancer development.

Indexed as

Models, BiologicalCation Transport ProteinsCell Transformation, NeoplasticCytoplasmHumansHydrogen-Ion ConcentrationOncogenesProton PumpsSodium-Hydrogen Exchanger 1Sodium-Hydrogen ExchangersCation Transport ProteinsProton PumpsSLC9A1 protein, humanSodium-Hydrogen Exchanger 1Sodium-Hydrogen Exchangersangiogenesisgrowth factorsinvasionNHE1pH and cancertumour microenvironment

Identifiers

PMID24493748
PMCPMC3917354
OpenAlexW2147680861

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.